ANXA5 and breast cancer: To better analyze E.A./CDDP combination impact on apoptotic process, breast cancer cells were double-stained with annexin V/7AAD after pretreatment with the E.A. (6 μg/mL) for 24 h before CDDP (5 and 10 μM) for 48 h.